In Re Chemtura Corp.

436 B.R. 286, 2010 Bankr. LEXIS 3120, 53 Bankr. Ct. Dec. (CRR) 189, 2010 WL 3521616
CourtUnited States Bankruptcy Court, S.D. New York
DecidedSeptember 7, 2010
Docket19-22424
StatusPublished
Cited by2 cases

This text of 436 B.R. 286 (In Re Chemtura Corp.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Chemtura Corp., 436 B.R. 286, 2010 Bankr. LEXIS 3120, 53 Bankr. Ct. Dec. (CRR) 189, 2010 WL 3521616 (N.Y. 2010).

Opinion

BENCH DECISION 1 ON DEBTORS’ OBJECTIONS, UNDER BANKRUPTCY CODE SECTION 502(e)(1)(B) AND STATE LAW, TO CLAIMS OF CORPORATE DIACE-TYL CLAIMANTS

ROBERT E. GERBER, Bankruptcy Judge.

In this contested matter in the jointly administered chapter 11 cases of Chemtu-ra Corporation (“Chemtura”) and its affiliates (collectively, the “Debtors”), the Debtors object to proofs of claim (collectively, the “Contribution Claims”) filed by 5 corporate entities (collectively, the “Corporate Claimants”), for contribution and/or indemnification with respect to amounts the Corporate Claimants might pay in the future in litigation against them. The Contribution Claims arise out of lawsuits asserted by various plaintiffs (“Tort Plaintiffs”) alleging injuries from exposure to the chemicals diacetyl and/or ace-toin (collectively, “diacetyl”), which at one time were used in the manufacture of butter flavorings.

The Debtors contend that the Contribution Claims, except to the extent premised on amounts already paid to Tort Plaintiffs, should be disallowed and expunged under Bankruptcy Code section 502(e)(1)(B). And the Debtors also contend, with respect to amounts actually paid, that por *289 tions of the Contribution Claims fail to establish contribution or indemnity liability under applicable state law.

Except for claims for reimbursement of defense costs, the Debtors’ objections will be sustained, and the Corporate Claimants’ claims will be expunged. My Findings of Fact and Conclusions of Law in connection with this determination follow.

Findings of Fact

From 1982 to 2005, Chemtura Canada Co./Cie 2 (“Chemtura Canada”), a wholly owned indirect subsidiary of Chemtura, manufactured and shipped diacetyl to Citrus & Allied Essences, Ltd. (“Citrus”). Citrus thereafter resold that diacetyl to certain customers in the United States. From 1998 to 2005, Chemtura acted as an intermediary, purchasing diacetyl from Chemtura Canada and then selling it to Citrus.

Starting in 2001, Tort Plaintiffs began filing lawsuits against various companies, including Chemtura and Chemtura Canada, alleging that exposure to diacetyl caused them personal injury. Before the commencement of these chapter 11 cases, Chemtura and Chemtura Canada had been named in approximately 28 lawsuits relating to diacetyl, 20 of which still remain pending. Various distributors, manufacturers, and suppliers who may have directly or indirectly purchased diacetyl from Chemtura and/or Chemtura Canada have also been named as defendants in lawsuits alleging injuries related to diacetyl exposure.

By the time of the October 30, 2009 deadline for the filings of proofs of claim, approximately 375 non-duplicative proofs of claim related to diacetyl were filed. The great bulk of the 375 were by Tort Claimants, but those claims also included the Contribution Claims filed by 7 Corporate Claimants. 3

The 7 Corporate Claimants originally consisted of Citrus; Ungerer & Company (“Ungérer”); Polarome International Inc. (“Polarome”); Givaudan Flavors Corporation (“Givaudan”); Flavor Concepts, Inc. (“Flavor Concepts”); FONA International, Inc. (“FONA”); and Spartan Chemical Company (“Spartan”). However, by the time of oral argument on this motion, the Debtors reached agreements resolving their objections with respect to Givaudan and FONA.

Through the Contribution Claims, the remaining Corporate Claimants seek contribution and/or indemnification from Chemtura for amounts the Corporate Claimants have allegedly already paid and may pay in the future with respect to diacetyl related lawsuits. The majority of the underlying Tort Plaintiffs relating to these Contribution Claims have also filed their own individual proofs of claim against Chemtura, although certain underlying Tort Plaintiffs have neglected to do so.

*290 In general, the Corporate Claimants assert claims against Chemtura of three types:

(1) For contribution and indemnity against Chemtura on account of those diacetyl related lawsuits in which Chem-tura was either a named party by the plaintiff, or otherwise brought into the litigation by one of the Corporate Claimants or another defendant; 4
(2) For contribution and indemnity on account of diacetyl related litigation which is currently pending against one of the Corporate Claimants but where Chemtura is not a named defendant and has not otherwise been brought into the litigation. 5
(3) on account of claims that the Corporate Claimants would bring against Chemtura if the Corporate Claimants were named in future diacetyl related litigation.

Citrus (Proof of Claim No. 9956)

Citrus is a supplier of essential oils, oleoresins, aromatic chemicals and specialty flavor ingredients to both resellers and end users of such products. As previously noted, between 1982 and 2005, Citrus was the exclusive reseller of diacetyl manufactured by Chemtura Canada and/or sold by Chemtura.

According to the Citrus proof of claim, Citrus has been named as a defendant in at least 28 lawsuits brought by Tort Plaintiffs “for essentially the same alleged conduct, namely the defendants’ alleged negligent design, testing, formulation, manufacture, marketing and selling of certain chemicals, including diacetyl and acetoin, which diacetyl and acetoin were purchased by Citrus from Chemtura and/or Chemtura Canada.” 6 The Citrus proof of claim asserts indemnity and contribution claims against Chemtura for all settled litigation, pending litigation, and future litigation that is “relating to or arising out of the purchase of any and all chemicals by Citrus from Chemtura, including but not limited to diacetyl and acetoin....” 7

The 28 lawsuits brought against Citrus involve 74 underlying Tort Plaintiffs. With respect to 63 of the 74 underlying Tort Plaintiffs’ claims, Citrus has yet to incur any obligation to such plaintiffs. With respect to the remaining 11 underlying Tort Plaintiffs’ claims, Citrus has made payments under various settlement agreements.

The Debtors objected to the unliquidat-ed portion of the Citrus proof of claim but, with 1 exception, have not objected to the portion of the Citrus proof of claim that is based on actual settlement payments. The exception is a settlement (the “Campbell Settlement”) that Citrus entered into with certain Tort Plaintiffs in Campbell v. International Flavors & Fragrances, et al. (the “Campbell Litigation”), in July 2009. In the Campbell Settlement, the plaintiffs released Citrus and certain other entities from any and all liability but expressly declined to release Chemtura and reserved all rights and claims as against Chemtura.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Chemtura Corporation
443 B.R. 601 (S.D. New York, 2011)
In Re Lyondell Chemical Co.
442 B.R. 236 (S.D. New York, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
436 B.R. 286, 2010 Bankr. LEXIS 3120, 53 Bankr. Ct. Dec. (CRR) 189, 2010 WL 3521616, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-chemtura-corp-nysb-2010.